IFNG and cancer: The potential applications of our findings may also include chimeric antigen receptor-modified T or NK cells (CAR-T or CAR-NK) as anti-cancer therapies, since CAR engagement with specific targets can induce higher levels of IFN-γ than native T and NK cells [111].